1991
DOI: 10.1016/0040-4039(91)80559-o
|View full text |Cite
|
Sign up to set email alerts
|

Novel synthesis of 19-nor-vitamin D compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
49
0

Year Published

2001
2001
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 99 publications
(49 citation statements)
references
References 15 publications
0
49
0
Order By: Relevance
“…Inhibition of clonal proliferation was evaluated in leukemia HL-60, breast cancer MCF-7, prostate PC-3 and LNCaP cell lines [14]. The results were compared with those obtained for 1 and summarized in Table 2.e 2 Significant separations of the immunomodulatory activity from hypercalcemic effects (MTD) were observed.…”
Section: Immunomodulatory Activity and Iinhibi-tion Of Cancer Cell CLmentioning
confidence: 99%
See 1 more Smart Citation
“…Inhibition of clonal proliferation was evaluated in leukemia HL-60, breast cancer MCF-7, prostate PC-3 and LNCaP cell lines [14]. The results were compared with those obtained for 1 and summarized in Table 2.e 2 Significant separations of the immunomodulatory activity from hypercalcemic effects (MTD) were observed.…”
Section: Immunomodulatory Activity and Iinhibi-tion Of Cancer Cell CLmentioning
confidence: 99%
“…The program benefited from our previous findings that biological activities could be enhanced, and the metabolic deactivation retarded, by introduction of a 23-double or triple bond, replacement of the C-25 geminal methyl groups with trifluoromethyl moieties and insertion of a 16-ene function. To broaden the basis of structure-activity relationships, we made liberal use of DeLuca's 19-nor modification [14] of the A-ring as shown in the following Scheme.…”
Section: Introductionmentioning
confidence: 99%
“…Ligand Pharmaceuticals identified the nonsecosteroidal activators of VDR upon screening of a compound library in cells, which were transfected with a reporter construct that contained a vitamin-Dresponsive element of the CYP24 promoter [57] (Table 76.12). A bis-phenyl derivative, LG190090, was characterized that was able to transactivate the reporter construct in a VDR-dependent manner (1000-fold less potent than 1,25(OH) 2 …”
Section: Non-secosteroidal Compoundsmentioning
confidence: 99%
“…Three different parts can be distinguished in the structure of 1,25(OH) 2 D 3 : a central rigid CD-bicyclic ring portion to which are connected at C-17 the flexible side chain and at C-8 the flexible seco-B,A-ring system. Many scientists focused on the introduction of chemical modifications into these flexible parts of the secosteroidal structure of 1,25(OH) 2 D 3 such as elongation, unsaturation, epimerization of the side chain or alterations of the A-ring such as the successful 19-nor modification which resulted in a 10-fold decreased calcemic activity of 1,25(OH) 2 D 3 [2,3]. Next to the introduction of structural modifications in the side chain or the A-ring, an extensive study of the structureefunction relationship was performed focusing on the least-studied CD-ring region.…”
Section: Introductionmentioning
confidence: 99%
“…2D-ASMA of these compounds was studied in comparison with the natural hormone (1) and the closely related 19-norvitamin D analog, 2MD (2) [19]. 19-Norvitamin D derivatives [19][20][21][22], which were first developed by DeLuca's group, are versatile analogs of vitamin D that are chemically stable and also easy to synthesized. …”
Section: Introductionmentioning
confidence: 99%